David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.55% |
| 2 | Consumer Discretionary | 8.97% |
| 3 | Financials | 8.5% |
| 4 | Healthcare | 8.44% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
CALL
Inhibrx
INBX
$1.84B
| $1.18M | ﹤0.01% |
17,600
| – | – |
|
3227
CALL
Turning Point Brands
TPB
$1.77B
| $1.18M | ﹤0.01% |
+13,600
| New | +$1.52M |
|
3228
CALL
Freshpet
FRPT
$3.6B
| $1.18M | ﹤0.01% |
20,000
-17,000
| -46% | -$1.19M |
|
3229
NextNav
NN
$2.6B
| $1.18M | ﹤0.01% |
73,543
-297,312
| -80% | -$4.81M |
|
3230
TFS Financial
TFSL
$5.03B
| $1.18M | ﹤0.01% |
+83,830
| New | +$1.19M |
|
|
STRZ
3231
Starz Entertainment Corp
STRZ
$489M
| $1.18M | ﹤0.01% |
102,292
-21,454
| -17% | -$240K |
|
|
BOBS
3232
Bobs Discount Furniture
BOBS
$2.24B
| $1.18M | ﹤0.01% |
+100,097
| New | +$1.71M |
|
3233
Sight Sciences
SGHT
$461M
| $1.17M | ﹤0.01% |
311,374
+78,512
| +34% | +$424K |
|
3234
PUT
Biogen
BIIB
$32.7B
| $1.17M | ﹤0.01% |
6,400
| – | – |
|
3235
CALL
Prudential Financial
PRU
$41.5B
| $1.17M | ﹤0.01% |
12,000
| – | – |
|
3236
Franklin Templeton
BEN
$17.8B
| $1.17M | ﹤0.01% |
49,619
+9,567
| +24% | +$246K |
|
3237
CALL
Antero Midstream
AM
$10.7B
| $1.17M | ﹤0.01% |
+51,300
| New | +$1.06M |
|
3238
Lithia Motors
LAD
$8.14B
| $1.17M | ﹤0.01% |
4,680
-73,606
| -94% | -$21.9M |
|
3239
CALL
Brown & Brown
BRO
$24.4B
| $1.17M | ﹤0.01% |
+17,900
| New | +$1.29M |
|
3240
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.95B
| $1.17M | ﹤0.01% |
+5,811
| New | +$1.2M |
|
3241
Seanergy Maritime Holdings
SHIP
$369M
| $1.17M | ﹤0.01% |
90,352
+49,157
| +119% | +$577K |
|
3242
VanEck BDC Income ETF
BIZD
$1.7B
| $1.16M | ﹤0.01% |
+90,697
| New | +$1.22M |
|
3243
James River Group Holdings
JRVR
$191M
| $1.16M | ﹤0.01% |
184,180
-242,877
| -57% | -$1.6M |
|
3244
OrthoPediatrics
KIDS
$627M
| $1.16M | ﹤0.01% |
73,071
-143
| -0.2% | -$2.5K |
|
3245
Burke & Herbert Financial Services Corp
BHRB
$1.45B
| $1.16M | ﹤0.01% |
18,596
-332
| -2% | -$21.5K |
|
3246
WIX.com
WIX
$3.44B
| $1.16M | ﹤0.01% |
12,826
-49,103
| -79% | -$4.11M |
|
3247
CALL
Xenon Pharmaceuticals
XENE
$6.18B
| $1.15M | ﹤0.01% |
+19,800
| New | +$912K |
|
3248
FIVE9
FIVN
$2.39B
| $1.15M | ﹤0.01% |
75,824
-24,100
| -24% | -$419K |
|
3249
PUT
CleanSpark
CLSK
$3.13B
| $1.15M | ﹤0.01% |
135,000
-130,000
| -49% | -$1.39M |
|
3250
CALL
OR Royalties Inc
OR
$7.2B
| $1.15M | ﹤0.01% |
30,200
-94,800
| -76% | -$3.89M |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.